Madrigal Pharmaceuticals sees rapid Rezdiffra sales growth with EU approval and long-term GLP-1 strategy. Learn why MDGL ...

Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the ...

PHOENIX — The oral medication resmetirom significantly improved liver stiffness and reduced portal hypertension in metabolic ...

Madrigal (MDGL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chando’s Tacos” posted a video on Facebook announcing the reopening of the business on Nov. 1, with a video from the owner, ...

The “Madrigal – Marin Constantin” National Chamber Choir will perform in Spain for the first time in 31 years as part of a ...

Andy Vigil, who once faced a possible death sentence and was told he'd serve the rest of his life in prison, was denied ...

Use that tab to limit the number of AI posts you see on your home feed by toggling the "switch to off" position. Pinterest says it's starting with categories that are highly prone to AI-generated or ...

Bill Sibold, Madrigal Pharma CEO, joins 'Fast Money' to talk how Rezdiffra stacks up to competitors in the MASH treatment space, sales growth for the drug over the last year, and more.

With the business potentially at an important milestone, we thought we'd take a closer look at Madrigal Pharmaceuticals, Inc.'s (NASDAQ:MDGL) future prospects. Madrigal Pharmaceuticals, Inc., a ...

Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast may be accessed at the ...

The only place to see the Madrigal family live! Coming to Golden 1 Center from October 30 – November 2, 2025 Sacramento, CA ...